Knight, B., Rassam, D., Liao, S., & Ewesuedo, R. (2016). A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers. Cancer Chemother Pharmacol.
Citação norma ChicagoKnight, Beverly, Danielle Rassam, Shanmei Liao, and Reginald Ewesuedo. "A Phase I Pharmacokinetics Study Comparing PF-06439535 (a Potential Biosimilar) With Bevacizumab in Healthy Male Volunteers." Cancer Chemother Pharmacol 2016.
Citação norma MLAKnight, Beverly, Danielle Rassam, Shanmei Liao, and Reginald Ewesuedo. "A Phase I Pharmacokinetics Study Comparing PF-06439535 (a Potential Biosimilar) With Bevacizumab in Healthy Male Volunteers." Cancer Chemother Pharmacol 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.